<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597812/" ref="ordinalpos=3251&amp;ncbi_uid=5917306&amp;link_uid=PMC3597812" image-link="/pmc/articles/PMC3597812/figure/F7/" class="imagepopup">FIGURE 7. From: Fucoidan Is a Novel Platelet Agonist for the C-type Lectin-like Receptor 2 (CLEC-2). </a></div><br /><div class="p4l_captionBody"><b>Model depicting tyrosine kinase-dependent signaling pathway in platelets activated with fucoidan.</b> Fucoidan activates platelets through an SFK-dependent pathway through the CLEC-2 receptor. YP represents tyrosine phosphorylation sites on the cytoplasmic domain of CLEC-2 receptor.</div></div>